 The purpose of the study is to determine whether use of the Berlin Heart EXCOR Pediatric Ventricular Assist Device for bridge-to-transplant is associated with a reasonable assurance of safety and probable benefit such that the EXCOR Pediatric merits approval by the Food and Drug Administration under a Humanitarian Device Exception HDE. 